In this article, we are going to take a look at where Abbott Laboratories (NYSE:ABT) stands against other best drug stocks to buy now. Large American pharmaceutical companies are showing a ...

Strategic Financial Concepts LLC purchased a new position in shares of Abbott Laboratories (NYSE:ABT – Free Report) during the 4th quarter, according to its most recent 13F filing with the SEC.

Texas Gov. Greg Abbott awarded $23.25 million to Austin-based Silicon Labs on Wednesday as part of the state's Semiconductor Innovation Fund. According to Abbott's announcement, the money will ...

On January 22, Abbott Laboratories published financial results for the fourth quarter of 2024, initially receiving mixed reactions from Wall Street. However, its revenue was about $10.97 billion ...

Shares of Abbott Laboratories ABT slipped 2.91% to $128.22 Thursday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index SPX rising 0.36% to 6,083 ...

In this article, we are going to take a look at where Abbott Laboratories (NYSE:ABT) stands against the other stocks. Jim Cramer, host of Mad Money, recently offered some important advice on how ...

Healthcare product and device company Abbott Laboratories (NYSE:ABT) in Q4 CY2024, with sales up 7.2% year on year to $10.97 billion. Its non-GAAP profit of $1.34 per share was in line with ...

Edwards Lifesciences beats profit estimate on strength in heart devices February 11, 2025 Abbott Laboratories on Wednesday forecast 2025 profit that came in line with Wall Street estimates as it ...

North Chicago, Illinois-based Abbott Laboratories (ABT) discovers, develops, manufactures, and sells healthcare products. Valued at $229.1 billion by market cap, ABT is a global leader in the ...

This month, we explore the 125-year-old history of Abbott Laboratories and its most significant milestone to date – the creation of its own independent company, AbbVie. In 1888, a 30-year-old ...